The medical community is buzzing by retatrutide, a innovative dual GIP and GLP-1 target that’s showing remarkable results in preliminary studies . This treatment works by mimicking natural hormones to regulate appetite and boost feelings of satiety, ultimately resulting in substantial weight decrease. While currently under review and not yet avai